advanced hcc: celestial trial
Published 4 years ago • 70 plays • Length 8:40Download video MP4
Download video MP3
Similar videos
-
1:46
results from the celestial trial for patients with advanced hcc
-
2:28
dr. abou-alfa discusses results of the celestial trial in advanced hcc
-
3:02
advanced hcc: imbrave150 trial
-
58:25
molecular targeted therapies for advanced hcc
-
6:08
imbrave150 trial: combination therapy in advanced hcc
-
47:42
immune therapy in hepatocellular carcinoma
-
1:30:40
calibrating hcc care: delivering effective tx with modern immunotherapy and targeted approaches
-
2:05
innovative treatments in liver cancer
-
1:40
comparing sorafenib and lenvatinib for the frontline treatment of advanced hcc
-
2:11
initial strategies in advanced hcc
-
3:11
regorafenib in advanced hcc
-
4:14
imbrave150 trial: frontline treatment of advanced hcc
-
2:12
future treatment landscape for advanced hcc
-
1:48
addressing how to treat patients with advanced hepatocellular carcinoma
-
1:38
celestial trial: assessing outcomes by afp levels in hcc
-
1:57
recent immunotherapy advances in hcc management
-
5:12
future treatment landscape of advanced hcc
-
2:33
celestial trial: second-line cabozantinib’s value in hcc
-
8:50
first-line therapy in advanced hcc
-
5:48
second-line therapy in advanced hcc
-
2:02
factors impacting treatment in advanced hcc
-
2:45
sequencing with cabozantinib in advanced hcc